Aribio announced on the 24th that it will participate in the Global Life Science Partnering & Investor Conference 2025, held in San Diego, USA, from the 25th to the 27th (local time).
More than 600 industry professionals from over 20 countries worldwide will attend this event. Aribio will be represented by Fred Kim, head of the US branch, and Tanya Xi, director of development strategy.
Mr. Kim will give an oral presentation on Aribio's technology and the Alzheimer's treatment project AR1001. He plans to actively engage in technology licensing negotiations with big pharma companies and meet with various partners and investors.
A company representative stated, "Since the JP Morgan Healthcare Conference held earlier this year, we have been closely discussing technology licensing (LO) and investment with global big pharma," adding, "We will continue existing discussions while also conducting productive meetings with new partners."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
